FDA Inspection 1202841 — Rohto Pharmaceutical Co., Ltd. (Ueno Plant)
The FDA completed an inspection of Rohto Pharmaceutical Co., Ltd. (Ueno Plant) on March 8, 2023 in Iga. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 8, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Iga (Japan)